All Effectiveness Bank analyses to date of documents related to alcohol compiled for our partner Alcohol Change UK, starting with the analyses most recently added or updated, totalling today 791 documents.
Click blue titles to view full text in a new window
Use the selectors at the bottom to turn to the next page in the list of documents
Wilson I.M., Graham K., Taft A.
BMC Public Health: 2014, 14(881), p. 1–11.
What constitutes ‘alcohol-related’ domestic abuse, and to what extent can interventions designed to reduce the harms of alcohol also reduce domestic abuse?
DOCUMENT 2017 HTM file
Commissioning impact on drug treatment: The extent to which commissioning structures, the financial environment and wider changes to health and social welfare impact on drug misuse treatment and recovery
Advisory Council on the Misuse of Drugs.
[UK] Advisory Council on the Misuse of Drugs, 2017.
Based on research, financial data and stakeholder surveys and testimonies, the UK government’s official drug policy advisers warn that without significant efforts to protect investment and quality, in England “loss of funding will result in the dismantling of a drug misuse treatment system that has brought huge improvement to the lives of people with drug and alcohol problems”.
Tanum L., Solli K.K., Latif Z.E. et al.
JAMA Psychiatry: 2017, 74(12), p. 1197–1205.
Can monthly injections of extended-release naltrexone be considered on a par with the standard daily opioid substitute in Norway for people wanting to maintain abstinence from heroin?
Public Health England
Public Health England, 2017.
The annual accounting of the treatment caseload in England registers a continuing fall in total numbers and decreasing success with opiate users, while success with drinkers has increased and has for the last few years remained relatively high and stable. An ageing population of opiate users is the proposed explanation for the former trend – but why hasn’t a similarly ageing alcohol caseload also eroded success rates?
Spoth R., Redmond C., Shin C. et al.
Preventive Medicine: 2013, 56, p. 190–196.
Evaluated drug prevention programmes for adolescents are typically implemented by research teams, raising questions over real-world applicability and sustainability, but an important US trial is said to have robustly demonstrated the public health potential of a system in which the communities themselves take primary responsibility.
HOT TOPIC 2017 HTM file
Focus on the families
Ashton M., Davies N.
‘Hot topics’ offer background and analysis on important issues which sometimes generate heated debate. Both as a treatment resource for the patient and a group needing support in their own right, a UK report described families affected by substance use as the “forgotten” carers. Here we turn the focus on the “unheard and unseen victims when a loved one uses drugs or alcohol”.
REVIEW 2017 HTM file
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
Palpacuer C., Duprez R., Huneau A. et al.
Addiction: 2017, in press.
In 2013 nalmefene was authorised for moderating drinking among patients not in need of detoxification, extending pharmacotherapy to less dependent drinkers. Though uniquely authorised for this purpose, this review found other (and probably cheaper) drugs have been just as or possibly more effective, but for none was there high quality evidence.
Samson J.E., Tanner-Smith E.E.
Journal of Studies on Alcohol and Drugs: 2015, 76(4), p. 530–543.
Personalised, interactive, and motivational approaches dominate in this study of the effectiveness of single-session brief interventions for heavy-drinking college students. But, overall the effects of brief interventions remain modest in clinical terms.
STUDY 2017 HTM file
Impact of financial incentives on alcohol consumption recording in primary health care among adults with schizophrenia and other psychoses: a cross-sectional and retrospective cohort study
Khadjesari Z., Hardoon S.L., Petersen I. et al.
Alcohol and Alcoholism: 2017, 52(2), p. 197–205.
UK study of how Quality and Outcomes Framework incentives for primary care boosted alcohol screening among patients with severe mental illness shows what could have happened had the incentives been extended across the entire primary care caseload.
COLLECTION 2017 HTM file
Alcohol and families
‘Collections’ are customised Effectiveness Bank searches not available via the standard options in the search pages. Constructed for Alcohol Awareness Week 2017 on the theme of ‘Alcohol and Families’, this collection includes both major roles for the families of problem drinkers – as recipients of support and therapy to promote their own welfare, and as therapeutic agents engaged in promoting the drinker’s welfare.
Select search results pagePREVIOUS | NEXT 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80